Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The referenced entity "SERPINB2-SERPINB10 readthrough" is not a well-validated or functionally characterized protein, but rather a predicted transcript overlapping two serpin family genes. The individual proteins, SERPINB2 (Plasminogen activator inhibitor 2, PAI-2) and SERPINB10 (Bomapin), are intracellular serine protease inhibitors in clade B of the serpin family. SERPINB2 plays roles in the regulation of cell senescence, inflammation, and protease activity, particularly affecting urokinase and tissue plasminogen activator. SERPINB10 regulates protease function during hematopoiesis and influences allergic airway inflammation. Both proteins are involved in immune system regulation, apoptosis, and have been implicated as biomarkers in various disease processes including cancer and inflammatory conditions.
For the individual proteins: - Protease inhibition: blocks serine protease activity (e.g., uPA, tPA for SERPINB2; trypsin, thrombin for SERPINB10). - Regulation of apoptosis (SERPINB10: affects TNF-induced apoptosis).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SERPINB2-SERPINB10 readthrough.